Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niels Teich

Showing results (81-90 of 115) with videos related to

Pageof 12
Sort By:
Zeitschrift Fur Gastroenterologie|May 13, 2017
Azathioprine allows glucocorticoid withdrawal - post hoc results of a prospective study in patients with inflammatory bowel diseasesNiels Teich, Wolfgang Mohl, Bernd Bokemeyer, et al.
Inflammatory Bowel Diseases|February 12, 2021
Colectomy Incidence Rates in Five-Year Data From the Observational Postmarketing Ulcerative Colitis Study of Originator InfliximabJulián Panés, James O Lindsay, Niels Teich, et al.
Visceral Medicine|February 10, 2025
Long-Term Sequelae of SARS-CoV-2 Infection in Patients with Inflammatory Bowel Diseases Compared to Relatives with SARS-CoV-2 Infection without Inflammatory Bowel Disease and Inflammatory Bowel Disease Patients without SARS-CoV-2: Results of a Retrospective Case-Control StudyBenedikt Bierbaum, Ulrike von Arnim, Renate Schmelz, et al.
Human Mutation|December 26, 2003
Interaction between trypsinogen isoforms in genetically determined pancreatitis: mutation E79K in cationic trypsin (PRSS1) causes increased transactivation of anionic trypsinogen (PRSS2)Niels Teich, Cédric Le Maréchal, Zoltán Kukor, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|May 13, 2010
Sequence analysis of the human tyrosylprotein sulfotransferase-2 gene in subjects with chronic pancreatitisJonas Rosendahl, Zsolt Rónai, Peter Kovacs, et al.
Journal of Crohn'S & Colitis|November 15, 2023
Treatment of Antibiotic Refractory Chronic Pouchitis With JAK Inhibitors and S1P Receptor Modulators: An ECCO CONFER Multicentre Case SeriesDavide Giuseppe Ribaldone, Giulia Testa, Bram Verstockt, et al.
World Journal of Gastroenterology|September 26, 2014
Parameters of a severe disease course in ulcerative colitisAndreas Stallmach, Luisa Nickel, Thomas Lehmann, et al.
Digestive Diseases (Basel, Switzerland)|November 2, 2022
Early MOnitoring of REsponse (MORE) to Golimumab Therapy: Results of a Multicentre, Prospective Observational TrialUlf Helwig, Thomas Helmut Krause, Christian Maaser, et al.
Therapeutic Advances in Gastroenterology|July 2, 2026
International collaborative experiences in managing pyoderma gangrenosum in patients with inflammatory bowel diseaseJan Guse, Andreas Blesl, Philip Esters, et al.
Biochemical and Biophysical Research Communications|July 23, 2005
Expression of mutated cationic trypsinogen reduces cellular viability in AR4-2J cellsSebastian Gaiser, Astrid Ahler, Felix Gundling, et al.
Pageof 12

Showing results (81-90 of 115) with videos related to

Sort By:
Pageof 12
Zeitschrift Fur Gastroenterologie|May 13, 2017
Azathioprine allows glucocorticoid withdrawal - post hoc results of a prospective study in patients with inflammatory bowel diseasesNiels Teich, Wolfgang Mohl, Bernd Bokemeyer, et al.
Inflammatory Bowel Diseases|February 12, 2021
Colectomy Incidence Rates in Five-Year Data From the Observational Postmarketing Ulcerative Colitis Study of Originator InfliximabJulián Panés, James O Lindsay, Niels Teich, et al.
Visceral Medicine|February 10, 2025
Long-Term Sequelae of SARS-CoV-2 Infection in Patients with Inflammatory Bowel Diseases Compared to Relatives with SARS-CoV-2 Infection without Inflammatory Bowel Disease and Inflammatory Bowel Disease Patients without SARS-CoV-2: Results of a Retrospective Case-Control StudyBenedikt Bierbaum, Ulrike von Arnim, Renate Schmelz, et al.
Human Mutation|December 26, 2003
Interaction between trypsinogen isoforms in genetically determined pancreatitis: mutation E79K in cationic trypsin (PRSS1) causes increased transactivation of anionic trypsinogen (PRSS2)Niels Teich, Cédric Le Maréchal, Zoltán Kukor, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|May 13, 2010
Sequence analysis of the human tyrosylprotein sulfotransferase-2 gene in subjects with chronic pancreatitisJonas Rosendahl, Zsolt Rónai, Peter Kovacs, et al.
Journal of Crohn'S & Colitis|November 15, 2023
Treatment of Antibiotic Refractory Chronic Pouchitis With JAK Inhibitors and S1P Receptor Modulators: An ECCO CONFER Multicentre Case SeriesDavide Giuseppe Ribaldone, Giulia Testa, Bram Verstockt, et al.
World Journal of Gastroenterology|September 26, 2014
Parameters of a severe disease course in ulcerative colitisAndreas Stallmach, Luisa Nickel, Thomas Lehmann, et al.
Digestive Diseases (Basel, Switzerland)|November 2, 2022
Early MOnitoring of REsponse (MORE) to Golimumab Therapy: Results of a Multicentre, Prospective Observational TrialUlf Helwig, Thomas Helmut Krause, Christian Maaser, et al.
Therapeutic Advances in Gastroenterology|July 2, 2026
International collaborative experiences in managing pyoderma gangrenosum in patients with inflammatory bowel diseaseJan Guse, Andreas Blesl, Philip Esters, et al.
Biochemical and Biophysical Research Communications|July 23, 2005
Expression of mutated cationic trypsinogen reduces cellular viability in AR4-2J cellsSebastian Gaiser, Astrid Ahler, Felix Gundling, et al.
Pageof 12